Commonwealth Equity Services, LLC Corbus Pharmaceuticals Holdings, Inc. Transaction History

Commonwealth Equity Services, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 31, 2022	SELL	$0.6 - $1.11 $7,186 - $13,295	-11,978 Closed	0 $0
Q3 2021 Oct 29, 2021	SELL	$1.01 - $1.82 $631 - $1,137	-625 Reduced 4.96%	11,978 $12,000
Q1 2021 May 04, 2021	SELL	$1.27 - $3.42 $5,003 - $13,474	-3,940 Reduced 23.82%	12,603 $24,000
Q4 2020 Feb 11, 2021	SELL	$0.94 - $1.89 $1,533 - $3,082	-1,631 Reduced 8.97%	16,543 $20,000
Q3 2020 Nov 05, 2020	BUY	$1.5 - $9.38 $9,103 - $56,927	6,069 Added 50.14%	18,174 $32,000
Q2 2020 Aug 12, 2020	BUY	$4.79 - $8.39 $57,982 - $101,560	12,105 New	12,105 $101,000

38.7K

Ticker CRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,268,000
Market Cap $1.66B
Description
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Commonwealth Equity Services, LLC with notifications on news.